SpaceX IPO High Valuation Raises Questions Amid Hype and Achievement BIS and Global Banks to Test Blockchain Prototype for Faster CrossBorder Payments Regulatory Turmoil States Challenge Prediction Markets as Federal Oversight Looms Kevin Warshs Potential Fed Regime Change Could Reshape Wall Streets Operational Framework White House Touts Soybean and Rare Earths Deals Following TrumpXi Summit Rocket Lab Shares Surge on 90 Million Catalyst What Investors Should Know Hut 8 Corp Q3 2024 Earnings EPS beats estimates as company navigates Bitcoin mining headwinds WDS Q4 2025 Earnings Earnings per share beat estimates by over 33 amid strong operational performance Pixelworks PXLW Q1 2026 Earnings Massive EPS Surprise Driven by Extraordinary Items Xponential Fitness Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction IDEX Corporation Q1 2026 Earnings EPS Surpasses Estimates by 117 ICU Q1 2026 Earnings WiderthanExpected Loss as Company Remains PreRevenue Haoxi Health Technology HAO Plunges 20 Testing Critical Support at 083 Expand Energy EXE Nears Resistance After Modest Decline Marten Transport Ltd MRTN Gains 22 as Shares Bounce Off Key Support Level Jowell Global Ltd JWEL Holds Steady Near Support After Modest Uptick Flag Ship Acquisition Corp Rights FSHPR Trading Steady Near 008 Amid Limited Activity Indian Markets Open Flat After Monday Rally Crude Oil Surges on USIran Tensions Select Water Solutions WTTR Q1 2026 Earnings Strong EPS Beat Masks Mixed Sentiment Shares Dip Despite Profit Surprise Hercules Capital Notes HCXY Slight Decline Amid Steady FixedIncome Trading BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Net Loss Widens Bond Prices Edge Higher ADSK Q1 2026 Earnings Strong EPS Beat Amid Uncertain Revenue Picture WMK Q3 2023 Earnings Reported EPS of 086 with Modest Stock Response NFBK Q1 2026 Earnings EPS Beats Estimates as Net Interest Margin Holds Steady OEC Q1 2026 Earnings Significant EPS Miss Amid Positive Stock Reaction BBLG Q1 2026 Earnings NarrowerthanExpected Loss as Bone Biologics Advances Development ACTU Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage